These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 24452632

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. "Set it and forget it": women's perceptions and opinions of long-acting topical vaginal gels.
    van den Berg JJ, Rosen RK, Bregman DE, Thompson LA, Jensen KM, Kiser PF, Katz DF, Buckheit K, Buckheit RW, Morrow KM.
    AIDS Behav; 2014 May; 18(5):862-70. PubMed ID: 24248674
    [Abstract] [Full Text] [Related]

  • 3. The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.
    Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH.
    J Womens Health (Larchmt); 2003 Sep; 12(7):655-66. PubMed ID: 14583106
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Vaginal film for prevention of HIV: using visual and tactile evaluations among potential users to inform product design.
    Guthrie KM, Rohan L, Rosen RK, Vargas SE, Shaw JG, Katz D, Kojic EM, Ham AS, Friend D, Buckheit KW, Buckheit RW.
    Pharm Dev Technol; 2018 Mar; 23(3):311-314. PubMed ID: 28592183
    [Abstract] [Full Text] [Related]

  • 7. Variations in microbicide gel acceptability among young women in the USA and Puerto Rico.
    Giguere R, Carballo-Diéguez A, Ventuneac A, Mabragaña M, Dolezal C, Chen BA, Kahn JA, Zimet GD, McGowan I.
    Cult Health Sex; 2012 Mar; 14(2):151-66. PubMed ID: 22084840
    [Abstract] [Full Text] [Related]

  • 8. Acceptability of tenofovir gel as a vaginal microbicide among women in a phase I trial: a mixed-methods study.
    Rosen RK, Morrow KM, Carballo-Diéguez A, Mantell JE, Hoffman S, Gai F, Maslankowski L, El-Sadr WM, Mayer KH.
    J Womens Health (Larchmt); 2008 Apr; 17(3):383-92. PubMed ID: 18328009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Willingness to use microbicides is affected by the importance of product characteristics, use parameters, and protective properties.
    Morrow KM, Fava JL, Rosen RK, Vargas S, Barroso C, Christensen AL, Woodsong C, Severy L.
    J Acquir Immune Defic Syndr; 2007 May 01; 45(1):93-101. PubMed ID: 17325607
    [Abstract] [Full Text] [Related]

  • 12. Designing preclinical perceptibility measures to evaluate topical vaginal gel formulations: relating user sensory perceptions and experiences to formulation properties.
    Morrow KM, Fava JL, Rosen RK, Vargas S, Shaw JG, Kojic EM, Kiser PF, Friend DR, Katz DF, Project Link Study Team.
    AIDS Res Hum Retroviruses; 2014 Jan 01; 30(1):78-91. PubMed ID: 24180360
    [Abstract] [Full Text] [Related]

  • 13. Muslim women's reflections on the acceptability of vaginal microbicidal products to prevent HIV infection.
    Hoel N, Shaikh S, Kagee A.
    Ethn Health; 2011 Apr 01; 16(2):89-106. PubMed ID: 21328113
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
    Miller L, Morar N, Kapiga S, Ramjee G, Hayes R.
    J Acquir Immune Defic Syndr; 2020 Dec 01; 85(4):458-465. PubMed ID: 33136745
    [Abstract] [Full Text] [Related]

  • 18. Qualitative exploration of intrinsic and extrinsic factors that influence acceptability of semisoft vaginal suppositories.
    Zaveri T, Powell KA, Guthrie KM, Bakke AJ, Ziegler GR, Hayes JE.
    BMC Womens Health; 2018 Oct 20; 18(1):170. PubMed ID: 30342510
    [Abstract] [Full Text] [Related]

  • 19. High-risk women's willingness to try a simulated vaginal microbicide: results from a pilot study.
    Mosack KE, Weeks MR, Novick Sylla L, Abbott M.
    Women Health; 2005 Oct 20; 42(2):71-88. PubMed ID: 16537301
    [Abstract] [Full Text] [Related]

  • 20. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
    Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.
    BMC Res Notes; 2012 Nov 01; 5():613. PubMed ID: 23116431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.